JP2011510936A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011510936A5 JP2011510936A5 JP2010544590A JP2010544590A JP2011510936A5 JP 2011510936 A5 JP2011510936 A5 JP 2011510936A5 JP 2010544590 A JP2010544590 A JP 2010544590A JP 2010544590 A JP2010544590 A JP 2010544590A JP 2011510936 A5 JP2011510936 A5 JP 2011510936A5
- Authority
- JP
- Japan
- Prior art keywords
- urea
- layer
- present
- therapeutic system
- transdermal therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102008006791.1 | 2008-01-30 | ||
| DE102008006791A DE102008006791B4 (de) | 2008-01-30 | 2008-01-30 | Transdermales Therapeutisches System mit Harnstoff-Komponente und Verfahren zu dessen Herstellung |
| PCT/EP2008/010426 WO2009095057A2 (de) | 2008-01-30 | 2008-12-09 | Transdermales therapeutisches system mit harnstoff-komponente |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011510936A JP2011510936A (ja) | 2011-04-07 |
| JP2011510936A5 true JP2011510936A5 (enExample) | 2011-07-21 |
| JP5389824B2 JP5389824B2 (ja) | 2014-01-15 |
Family
ID=40386379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010544590A Expired - Fee Related JP5389824B2 (ja) | 2008-01-30 | 2008-12-09 | 尿素成分を有する経皮治療システム |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9066887B2 (enExample) |
| EP (1) | EP2234605B1 (enExample) |
| JP (1) | JP5389824B2 (enExample) |
| KR (1) | KR20100105866A (enExample) |
| CN (1) | CN101909607B (enExample) |
| AU (1) | AU2008349007B2 (enExample) |
| BR (1) | BRPI0821975B8 (enExample) |
| CA (1) | CA2710640C (enExample) |
| DE (1) | DE102008006791B4 (enExample) |
| ES (1) | ES2548295T3 (enExample) |
| MX (1) | MX2010008334A (enExample) |
| PL (1) | PL2234605T3 (enExample) |
| WO (1) | WO2009095057A2 (enExample) |
| ZA (1) | ZA201004012B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106333939A (zh) * | 2016-10-09 | 2017-01-18 | 常州亚环环保科技有限公司 | 一种药用透皮材料的制备方法 |
| CN109549929A (zh) * | 2017-09-27 | 2019-04-02 | 天津金耀集团有限公司 | 一种有机固体溶液降低皮质激素药物粒径的方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1404583A (en) * | 1971-10-08 | 1975-09-03 | Vymatt Sa | Urea compositions and methods of preparation thereof |
| CS164542B1 (enExample) * | 1973-02-15 | 1975-11-07 | ||
| AU521982B2 (en) * | 1978-06-16 | 1982-05-13 | Phares Pharmaceutical Research N.V. | Pharmaceuticals with urea incuusion compounds |
| US4687481A (en) * | 1984-10-01 | 1987-08-18 | Biotek, Inc. | Transdermal drug delivery system |
| US4699777A (en) * | 1985-08-21 | 1987-10-13 | Schering Corporation | Compositions and method for enhancement of the transdermal flux of albuterol with a combination of 1-dodecyl-azacyclopheptan-2-one and urea |
| US5230896A (en) * | 1989-10-12 | 1993-07-27 | Warner-Lambert Company | Transdermal nicotine delivery system |
| DE4210165A1 (de) * | 1991-07-30 | 1993-02-04 | Schering Ag | Transdermale therapeutische systeme |
| DE4310012A1 (de) | 1993-03-27 | 1994-09-29 | Roehm Gmbh | Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung |
| AU2576797A (en) * | 1996-04-22 | 1997-11-12 | Toyama Chemical Co. Ltd. | Patch containing 1,2-ethanediol derivatives or salts thereof |
| DE19701949A1 (de) | 1997-01-13 | 1998-07-16 | Jenapharm Gmbh | Transdermales therapeutisches System |
| FR2761889B1 (fr) * | 1997-04-11 | 1999-12-31 | Oreal | Patch pharmaceutique, cosmetique ou dermo-pharmaceutique pour la delivrance de plusieurs composes actifs de nature differente |
| US20040018241A1 (en) * | 1997-09-26 | 2004-01-29 | Noven Pharmaceuticals, Inc. | Bioadhesive compositions and methods for topical administration of active agents |
| GB9826656D0 (en) * | 1998-12-03 | 1999-01-27 | Novartis Ag | Organic compounds |
| AU2002214364B2 (en) * | 2000-11-06 | 2004-08-19 | Samyang Biopharmaceuticals Corporation | Transdermal drug delivery system with improved water absorbability and adhesion properties |
| DK1341515T3 (da) * | 2000-12-15 | 2007-01-29 | Intendis Gmbh | Vandfri hudplejeformuleringer, der omfatter mikroniseret urinstof, og fremgangsmåde til fremstilling af samme |
| US20050020658A1 (en) * | 2002-11-21 | 2005-01-27 | Katsuyuki Inoo | Selective cyclooxygenase-2 inhibitor patch |
| FR2867978B1 (fr) * | 2004-03-29 | 2009-02-20 | Galderma Res & Dev | Patch d'amorolfine pour le traitement de l'onychomicose |
| DE102004028284A1 (de) | 2004-06-11 | 2006-01-05 | Hexal Ag | Matrixkontrolliertes transdermales therapeutisches System auf Basis eines Schmelzklebstoffs zur Anwendung von Norelgestromin |
-
2008
- 2008-01-30 DE DE102008006791A patent/DE102008006791B4/de active Active
- 2008-12-09 ES ES08871775.6T patent/ES2548295T3/es active Active
- 2008-12-09 US US12/865,465 patent/US9066887B2/en active Active
- 2008-12-09 EP EP08871775.6A patent/EP2234605B1/de active Active
- 2008-12-09 KR KR1020107017007A patent/KR20100105866A/ko not_active Ceased
- 2008-12-09 MX MX2010008334A patent/MX2010008334A/es active IP Right Grant
- 2008-12-09 CN CN200880124963.5A patent/CN101909607B/zh not_active Expired - Fee Related
- 2008-12-09 CA CA2710640A patent/CA2710640C/en active Active
- 2008-12-09 BR BRPI0821975A patent/BRPI0821975B8/pt not_active IP Right Cessation
- 2008-12-09 AU AU2008349007A patent/AU2008349007B2/en not_active Expired - Fee Related
- 2008-12-09 WO PCT/EP2008/010426 patent/WO2009095057A2/de not_active Ceased
- 2008-12-09 JP JP2010544590A patent/JP5389824B2/ja not_active Expired - Fee Related
- 2008-12-09 PL PL08871775T patent/PL2234605T3/pl unknown
-
2010
- 2010-06-04 ZA ZA2010/04012A patent/ZA201004012B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010510260A5 (enExample) | ||
| JP5881935B2 (ja) | 活性物質の利用率及び用量精度の高い経皮治療システム | |
| JP2016504368A5 (enExample) | ||
| JP5542665B2 (ja) | マトリックス型経皮投与剤およびその製造方法 | |
| JP2016502989A5 (enExample) | ||
| JP2022552017A (ja) | 抗菌オルガノシラン | |
| JP2013079281A5 (enExample) | ||
| BR112012019374A2 (pt) | composição farmacêutica, pellet de liberação prolongada, composição farmacêutica oral, método para tratamento de uma doença neurodegenerativa ou um dano ao sistema nervoso em um indivíduo necessitado do mesmo e método para preparação de uma formulação de liberação prolongada de um agente ativo | |
| NZ589542A (en) | Transdermal drug delivery system comprising an active agent in amorphous form and polyvinylpyrrolidone | |
| JP2017039781A5 (enExample) | ||
| WO2015200472A1 (en) | Transdermal delivery system | |
| JP2008517934A5 (enExample) | ||
| DE50311477D1 (de) | Hormonhaltiges transdermales therapeutisches system mit einem wirkstoffreservoir auf der basis von vinylacetat-vinylpyrrolidon-copolymer mit verbesserter kohäsion. | |
| JP2011510936A5 (enExample) | ||
| TW201143817A (en) | Transdermally absorbed preparation of anti-dementia drug | |
| JP6516917B2 (ja) | 貼付剤 | |
| JP2021020959A (ja) | ラベンダー油を含有する経皮治療システム | |
| HK1220125A1 (zh) | 拉喹莫德的透皮配方 | |
| JPH10330247A5 (enExample) | ||
| JP5389824B2 (ja) | 尿素成分を有する経皮治療システム | |
| JP7685984B2 (ja) | アクリルポリマーおよび接着剤組成物 | |
| HRP20170292T1 (hr) | Transdermalni flasteri niske doze s visokim otpuštanjem lijeka | |
| HK1151716B (en) | Transdermal therapeutic system having urea components | |
| TH155327A (th) | ระบบรักษาโรคผ่านผิวหนังสำหรับการให้สารออกฤทธิ์ | |
| JP2006141929A (ja) | 外用貼付剤 |